Business StandardCenter·
Hospital chains weigh drug price cap impact as Supreme Court scrutiny looms
Fortis flags potential margin pressure, while Manipal and Aster see limited impact as hospital chains assess drug pricing restrictions and await Supreme Court proceedings
Read at Business Standard →




